Terms: = Breast cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
74 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. Immune checkpoint status and exhaustion-related phenotypes of CD8
Yilmaz I; Tavukcuoglu E; Horzum U; Yilmaz KB; Akinci M; Gulcelik MA; Oral HB; Esendagli G
Cancer Med; 2023 Dec; 12(24):22196-22205. PubMed ID: 38069525
[TBL] [Abstract] [Full Text] [Related]
3. The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients.
Leinert E; Lukac S; Schwentner L; Coenen A; Fink V; Veselinovic K; Dayan D; Janni W; Friedl TWP
Surg Oncol; 2024 Feb; 52():102016. PubMed ID: 38056112
[TBL] [Abstract] [Full Text] [Related]
4. TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for breast cancer Cells with Mesenchymal Properties.
Giotopoulou N; Shi W; Parniewska MM; Sun W; Fuxe J
J Mammary Gland Biol Neoplasia; 2023 Dec; 28(1):25. PubMed ID: 38055067
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Peripheral Blood Lymphocytes on Prognosis of Multiple cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract] [Full Text] [Related]
6. Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With breast cancer: A Quality Improvement Study.
Conroy M; Kamaraju S; Powell M; Harris A; Beckius A; Nagavally S; Dawson A; Min H; Wright T; Wainaina N; Binder AF
Clin Breast Cancer; 2023 Oct; 23(7):e434-e440. PubMed ID: 37482498
[TBL] [Abstract] [Full Text] [Related]
7. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
Congur I; Koni E; Onat OE; Tokcaer Keskin Z
PeerJ; 2023; 11():e15250. PubMed ID: 37096065
[TBL] [Abstract] [Full Text] [Related]
9. Factors associated with breast cancer mammography screening and breast self-examination in Irish women: results from the Irish Longitudinal Study on Ageing (TILDA).
O'Sullivan K; O'Donovan A
Acta Oncol; 2022 Nov; 61(11):1301-1308. PubMed ID: 36369703
[TBL] [Abstract] [Full Text] [Related]
10. [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer].
Guo L; Ma Y; Li T; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1267-1278. PubMed ID: 36210698
[TBL] [Abstract] [Full Text] [Related]
11. E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in breast cancer.
Ye X; Zhou J; Tong D; Wang D; Wang H; Guo J; Kang X
Dis Markers; 2022; 2022():8168517. PubMed ID: 36164372
[TBL] [Abstract] [Full Text] [Related]
12. Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers.
Jones T; Silverman T; Guzman A; McGuinness JE; Trivedi MS; Kukafka R; Crew KD
BMC Med Inform Decis Mak; 2022 Aug; 22(1):208. PubMed ID: 35927732
[TBL] [Abstract] [Full Text] [Related]
13. Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.
Rethacker L; Boy M; Bisio V; Roussin F; Denizeau J; Vincent-Salomon A; Borcoman E; Sedlik C; Piaggio E; Toubert A; Dulphy N; Caignard A
Oncoimmunology; 2022; 11(1):2057396. PubMed ID: 35371620
[TBL] [Abstract] [Full Text] [Related]
14. The influence of a supervised group exercise intervention combined with active lifestyle recommendations on breast cancer survivors' health, physical functioning, and quality of life indices: study protocol for a randomized and controlled trial.
Riani Costa LA; F Barreto R; de Leandrini SMM; Gurgel ARB; de Sales GT; Voltarelli VA; de Castro G; Fenton SAM; Turner JE; Klausener C; Neves LM; Ugrinowitsch C; Farah JC; Forjaz CLM; Brito CMM; Brum PC
Trials; 2021 Dec; 22(1):934. PubMed ID: 34922621
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell profiling defines the prognostic benefit of CD39
Losurdo A; Scirgolea C; Alvisi G; Brummelman J; Errico V; Di Tommaso L; Pilipow K; Colombo FS; Fernandes B; Peano C; Testori A; Tinterri C; Roncalli M; Santoro A; Mazza EMC; Lugli E
Commun Biol; 2021 Sep; 4(1):1117. PubMed ID: 34552178
[TBL] [Abstract] [Full Text] [Related]
16. Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters.
Jørgensen N; Lænkholm AV; Sækmose SG; Hansen LB; Hviid TVF
Clin Immunol; 2021 Nov; 232():108847. PubMed ID: 34506945
[TBL] [Abstract] [Full Text] [Related]
17. Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis.
Cattin S; Fellay B; Calderoni A; Christinat A; Negretti L; Biggiogero M; Badellino A; Schneider AL; Tsoutsou P; Pellanda AF; Rüegg C
Breast Cancer Res; 2021 Jun; 23(1):64. PubMed ID: 34090509
[TBL] [Abstract] [Full Text] [Related]
18. Multiplexed digital spatial profiling of invasive breast tumors from Black and White women.
Omilian AR; Sheng H; Hong CC; Bandera EV; Khoury T; Ambrosone CB; Yao S
Mol Oncol; 2022 Jan; 16(1):54-68. PubMed ID: 34018684
[TBL] [Abstract] [Full Text] [Related]
19. Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data.
Jiang YQ; Wang ZX; Zhong M; Shen LJ; Han X; Zou X; Liu XY; Deng YN; Yang Y; Chen GH; Deng W; Huang JH
Oncoimmunology; 2021 Apr; 10(1):1908010. PubMed ID: 33868792
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological characteristics and prognostic marker of triple-negative breast cancer in older women.
Honma N; Ogata H; Yamada A; Matsuda Y; Kontani K; Miyashita M; Arai T; Sasaki E; Shibuya K; Mikami T; Sawaki M
Hum Pathol; 2021 May; 111():10-20. PubMed ID: 33548251
[TBL] [Abstract] [Full Text] [Related]
[Next]
